Supplement sales banned
Long-term health risks of 'andro' cited by FDA
The US Food and Drug Administration yesterday moved to halt sales of androstenedione, a dietary supplement marketed as a muscle enhancer that officials said can stunt growth in children and cause problematic sexual changes in adults. (Full Article: 819 Words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 Article
- $9.95 4 Articles
- $99.95 Unlimited
